EUVIMEDEUVIMED entdecken
Crossref

Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance

Eleonora Petito, Giuseppe Guglielmini, Edoardo De Robertis, Cecilia Becattini, Laura Franco, Emanuela Falcinelli, Chiara Conti, Fabio Gori, Gaetano Vaudo, Vittorio Cerotto, Ugo Paliani, Letizia Mezzasoma und 3 weitere

Thrombosis and Haemostasis · 01.07.2025 · 125 (07) · 660-672

DOI: 10.1055/a-2562-4516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.07.2025. Verfasst von Eleonora Petito und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy. Hauptthemen laut MEDLINE: COVID-19, Reactive Oxygen Species, Nitric Oxide, Blood Platelets. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress has been associated with COVID-19-related thrombotic complications. No investigations have explored nitric oxide (NO) and radical oxygen species (ROS) production by platelets. Indeed, activated platelets generate both NO and ROS which in turn regulate platelet function. The aim of the present study was to measure platelet NO and ROS production in COVID-19 patients, to assess whether they correlate with disease outcome and to clarify the mechanisms of platelet NO/ROS imbalance in COVID-19. Hospitalized mild and severe COVID-19 patients, age- and sex-matched healthy controls, and patients hospitalized in intensive care units for reasons different from COVID-19 were enrolled. Platelet NO and ROS production was assessed by flow cytometry. The oxidant and antioxidant capacity of COVID-19 plasma was assessed using lipid peroxidation and ORAC assays. The effect of COVID-19 plasma on platelet NO production and the impact of antioxidants on it were studied by flow cytometry. Platelets from COVID-19 patients displayed an altered NO/ROS balance, with defective NO and increased ROS production. Platelet NO production was significantly lower in patients who developed thrombotic events during hospitalization. COVID-19 patients showed significantly increased plasma lipid peroxidation and reduced antioxidant capacity compared with healthy controls. Concordantly, plasma from COVID-19 patients impaired NO production by healthy control species platelets, which was restored by the antioxidant agent Hydroxy-TEMPO. Our findings suggest that the unbalanced platelet NO/ROS production in COVID-19 plays a role in the thrombotic complications of SARS-CoV-2 infection. The restoration of platelet NO production may represent a therapeutic target for the prevention of thrombotic events in COVID-19 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Reactive Oxygen SpeciesNitric OxideBlood PlateletsHumansMaleFemaleMiddle AgedAgedOxidative StressThrombosisCase-Control StudiesLipid PeroxidationAdultSARS-CoV-2Antioxidants

Substanzen

Reactive Oxygen SpeciesNitric OxideAntioxidants

Autor:innen und Institutionen

  • Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
  • Division of Anaesthesia, Analgesia, and Intensive Care, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Section of Anesthesia, Intensive Care, and Pain Medicine, Azienda Ospedaliera-Universitaria Santa Maria della Misericordia, Perugia, Italy.
  • Unit of Internal Medicine, Terni University Hospital, Terni, Italy.
  • Section of Anesthesia, Intensive Care and Pain Medicine, Department of Emergency and Urgency, Città di Castello Hospital, Città di Castello, Italy.
  • Division of Internal Medicine, ASL 1 Umbria, Città di Castello, Italy.

ORCID-Profile: Paolo Gresele

Zitieren

APA

Petito, E., Guglielmini, G., De Robertis, E., Becattini, C., Franco, L., Falcinelli, E., Conti, C., Gori, F., Vaudo, G., Cerotto, V., Paliani, U., Mezzasoma, L., Camilloni, B., Gresele, P., & COVIR study investigators (2025). Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance. Thrombosis and Haemostasis, 125(07), 660-672. https://doi.org/10.1055/a-2562-4516

Vancouver

Petito E, Guglielmini G, De Robertis E, Becattini C, Franco L, Falcinelli E, et al. Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance. Thrombosis and Haemostasis. 2025;125(07):660-672. doi:10.1055/a-2562-4516

BibTeX
@article{Petito2025,
  author = {Petito, Eleonora and Guglielmini, Giuseppe and De Robertis, Edoardo and Becattini, Cecilia and Franco, Laura and Falcinelli, Emanuela and Conti, Chiara and Gori, Fabio and Vaudo, Gaetano and Cerotto, Vittorio and Paliani, Ugo and Mezzasoma, Letizia and Camilloni, Barbara and Gresele, Paolo and COVIR study investigators, COVIR study investigators},
  title = {Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance},
  journal = {Thrombosis and Haemostasis},
  year = {2025},
  volume = {125},
  number = {07},
  pages = {660--672},
  doi = {10.1055/a-2562-4516}
}
Kostenlos starten →